NEO vs ULS: stock comparison and AI forecast
Neogenomics Inc (NEO) and Ul Solutions Inc. (ULS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
NEO Neogenomics Inc
- Market Cap
- $2.13B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
ULS Ul Solutions Inc.
- Market Cap
- $15.37B
- P/E Ratio
- 26.7x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ULS is 7.2 times larger than NEO by market capitalization ($15.37B against $2.13B).
- ULS carries 1.15 times debt per unit of equity, against 0.72 times for NEO.
- ULS yields 0.74% in dividends; NEO pays none.
- Both companies share the SEC industry classification Services-Testing Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | NEO | ULS |
|---|---|---|
| Market Cap | $2.13B | $15.37B |
| P/E Ratio | – | 26.72x |
| P/B Ratio | 2.66x | 9.03x |
| Dividend Yield | – | 0.74% |
| EPS | $-0.58 | $2.85 |
| Book Value/Share | $6.19 | $8.43 |
| Revenue/Share | $6.09 | $15.78 |
| FCF/Share | $-0.22 | $2.38 |
Profitability & Margins
| Metric | NEO | ULS |
|---|---|---|
| ROE | – | 30.1% |
| ROA | – | 13.9% |
| ROIC | -3.9% | 20.0% |
| Gross Margin | 44.8% | 50.6% |
| Operating Margin | -6.3% | 17.8% |
| Net Margin | – | 16.1% |
| EBT Margin | -4.6% | 23.0% |
| Tax Rate | 10.7% | 26.4% |
Financial Health
| Metric | NEO | ULS |
|---|---|---|
| Current Ratio | 3.53x | 2.09x |
| Quick Ratio | 3.31x | – |
| D/E Ratio | 0.72x | 1.15x |
| Financial Leverage | 1.72x | 2.17x |
| Interest Coverage | -9.6x | 11.6x |
| Working Capital | $294M | $928M |
Cash Flow
| Metric | NEO | ULS |
|---|---|---|
| Operating Cash Flow | $4M | $738M |
| Free Cash Flow | -$29M | $481M |
| Capital Spending | -$33M | -$257M |
| OCF Growth YoY | -68.7% | 25.9% |
| FCF Growth YoY | – | 23.6% |
| FCF/Sales | -3.6% | 15.1% |
| CapEx/Sales | 4.2% | 8.1% |
Operational Efficiency
| Metric | NEO | ULS |
|---|---|---|
| Asset Turnover | 0.57x | 0.86x |
| Receivables Turnover | 3.7x | 7.1x |
| Inventory Turnover | 17.1x | – |
| Fixed Assets Turnover | 9.2x | 4.0x |
| Days Sales Outstanding | 99 days | 51 days |
| Days Inventory | 21 days | – |
| Payables Period | 28 days | 41 days |
| Cash Conversion Cycle | 93 days | – |
Income Statement
| Metric | NEO | ULS |
|---|---|---|
| Total Revenue | $788M | $3.19B |
| Operating Income | -$49M | $568M |
| Net Income | – | $513M |
| R&D Expense | $39M | – |
| SG&A Expense | $416M | $1.01B |
| Cost of Goods Sold | $435M | $1.57B |
Dividend & Shareholder Information
| Metric | NEO | ULS |
|---|---|---|
| Dividends Per Share | – | $0.56 |
| Payout Ratio | – | 19.6% |
| Shares Outstanding | 129M | 202M |
| Net Income Growth | – | 51.3% |
| EPS Growth | – | 70.7% |
NEO vs ULS: stock comparison and AI forecast
Which is bigger, NEO or ULS?
ULS is 7.2 times larger than NEO by market capitalization ($15.37B against $2.13B).
Which one does Intratio's AI model rank higher, NEO or ULS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.